Multicenter prospective validation of PanClaudinAI: An AI for predicting Claudin 18.2 from CT in pancreatic cancer. This is an ASCO Meeting Abstract from the 2026 ASCO Gastrointestinal Cancers ...
Larotrectinib in Patients With Tumors With NTRK Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E Advancements in profiling technologies have deepened our ...
While understanding the cellular diversity within tissue types is critical to understanding biological systems, established methods often lack the simultaneous subcellular resolution and multiplexing ...
Funding will be used to establish the clinical utility of OneMap™, a proprietary artificial intelligence (AI) driven single cell transcriptomic oncology platform, to guide treatment decisions, patient ...
A high-throughput workflow integrates DNA methylation and RNA sequencing in single cells, enabling more complete insights ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results